Dyslipidemia is a major risk factor for cardiovascular events and mortality. Numerous studies have demonstrated that statins reduce cardiovascular events and mortality in secondary prevention and primary prevention trials. In eight expertly authored chapters, Advances in Dyslipidemia provides an excellent overview for any physician taking care of patients with atherosclerotic vascular disease or at high-risk or moderate-risk for atherosclerotic vascular disease.
